VRDN Viridian Therapeutics, Inc.

HealthcareBiotechnology
$16.97
▼ 3.19%
37
QScore Signal
Hold
Confidence: MEDIUM
Long-Term
32
Short-Term
43

Value

14
P/E-4.81
8
P/B2.73
46
P/S20.30
0
EV/EBITDA-3.47
5

Growth

65
Revenue Growth23359.9%
100
EPS Growth16.6%
44
FCF Growth-18.9%
42

Momentum

53
12-Month Return41.3%
78
3-Month Return-41.7%
0
1-Month Return17.5%
85
RSI (14)62.04
73
50/200 MABearish
30

Profitability

20
ROE-60.7%
40
ROA-45.7%
0
Gross Margin99.3%
78
Operating Margin-543.9%
0
Net Margin-508.5%
0
FCF Yield-21.1%
0

Risk

34
Beta0.82
75
60-Day Volatility125.0%
0

Generated 5/7/2026, 9:56:10 PM · How is this calculated?

QScore Analysis